Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) Director Jan Skvarka sold 5,000 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $25.05, for a total transaction of $125,250.00. Following the transaction, the director now directly owns 47,970 shares of the company’s […]